JPRN-UMIN000020939已完成未知
The Effect of Xanthine Oxidase Inhibitor in ChronIc heart failure patients complicaTED with hyper-UricemiA : A (Prospective) Randomized Controlled Clinical Trial of Topiroxostat and Alloprinol - The Effect of Xanthine Oxidase Inhibitor in ChronIc heart failure patients complicaTED with hyper-UricemiA (Excite-UA study)
Dokkyo Medical University Department of Cardiovascular Medicine0 个研究点目标入组 140 人开始时间: 2016年2月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who fall into any of the following criteria are excluded from participating in the study. 1.Have a history of hypersensitivity to the test drug 2.Currently on medication of mercaptopurine hydrate or azathioprine 3.Currently have a severe liver failure (AST or ALT level is doubled from the standard values provided by each hospital/clinic) 4.Complicated with chronic liver disease, malignant tumor, active infection, or inflammatory disease 5.Currently have gout arthritis or the disease is cured for less than two weeks 6.Currently have nephrolithiasis or on treatment 7.eGFR is below 30 ml/min/1.73 square meters (CCr 30ml/min) 8.Currently have acute heart failure 9.After acute exacerbation improvement in chronic heart failure is less than two weeks 10. Currently pregnant or possibly conceived a child, or brest feeding 11.Other conditions that physicians judge to be inappropriate to be in the study
研究者
相似试验
进行中（未招募）
1 期
Allopurinol, brain lesions, heart size and blood pressure after ischaemic strokeEUCTR2013-004235-77-GBHS Greater Glasgow & Clyde464
进行中（未招募）
不适用
Do Xanthine Oxidase Inhibitors reduce both Left Ventricular Hypertrophy and Vascular Dysfunction in Cardiovascular patients with Renal Dysfunction? - Allopurinol in LVH/CKD trialChronic Kidney Disease Stage 3Left Ventricular HypertrophyMedDRA version: 9.1Level: LLTClassification code 10025164Term: LVHMedDRA version: 9.1Level: LLTClassification code 10064848Term: Chronic kidney diseaseEUCTR2007-004760-49-GBniversity of Dundee60
尚未招募
不适用
Treatment of Oral Submucous Fibrosis with Xanthinol Nicotinate, Dexamethasone and Levamisole.CTRI/2019/05/019008Dr Shaikh Saba Sultana
已完成
不适用
The association of circulating xanthine oxidase activity and purines with peripheral neuropathy or cognitive functions in type 2 diabetes.Type 2 diabetesJPRN-UMIN000029970Yokohama City University200
已完成
不适用
Do xanthine oxidase inhibitors reduce both left ventricular hypertrophy and endothelial dysfunction in cardiovascular patients with renal dysfunction?Chronic kidney disease (CKD) and left ventricular hypertrophy (LVH)Circulatory SystemComplications and ill-defined descriptions of heart diseaseISRCTN45773760niversity of Dundee (UK)60